|MolMed S p A -- Germany Stock|| |
EUR 0.54 0.01 1.89%
We currently do not have informatin regarding Alberto Carletti. This executive tanure with MolMed S p A is not currenlty determined.
Age: 56 Director Since 2012
39 02 21 27 71 http://www.molmed.com
The company has return on total asset (ROA)
of (18.1) %
which means that it has lost $18.1 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (61.21) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 964 K in total debt with debt to equity ratio (D/E) of 6.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. MolMed S p A has Current Ratio of 1.37 which is within standard range for the sector.
MolMed S.p.A., a medical biotechnology company, focuses on the research, development, and clinical validation of anticancer therapies. MolMed S.p.A. was founded in 1996 and is headquartered in Milan, Italy. MolMed S is traded on Frankfurt Stock Exchange in Germany.MolMed S p A (4HW) is traded on Frankfurt Stock Exchange in Germany. It is located in Via Olgettina, 58 and employs 23 people.